Literature DB >> 35985169

Molecular tools for probing the microbiome.

Marcelo Der Torossian Torres1, Cesar de la Fuente-Nunez2.   

Abstract

The microbiome plays essential roles in health and disease. Our understanding of the imbalances that can arise in the microbiome and their consequences is held back by a lack of technologies that selectively knock out members of these microbial communities. Antibiotics and fecal transplants, the existing methods for manipulating the microbiota of the gastrointestinal tract, are not sufficiently pinpointed to reveal how particular microbial genes, strains, or species affect human health. A toolset for the precise manipulation of the microbiome could significantly advance disease diagnosis and treatment. Here, we provide an overview of current and future strategies for the development of molecular tools that can be used to probe the microbiome without producing off-target effects.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35985169      PMCID: PMC9576005          DOI: 10.1016/j.sbi.2022.102415

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   7.786


  42 in total

Review 1.  Microbiome: Focus on Causation and Mechanism.

Authors:  Michael A Fischbach
Journal:  Cell       Date:  2018-08-09       Impact factor: 41.582

2.  A metagenomic strategy for harnessing the chemical repertoire of the human microbiome.

Authors:  Yuki Sugimoto; Francine R Camacho; Shuo Wang; Pranatchareeya Chankhamjon; Arman Odabas; Abhishek Biswas; Philip D Jeffrey; Mohamed S Donia
Journal:  Science       Date:  2019-10-03       Impact factor: 47.728

3.  Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation.

Authors:  David T Riglar; Tobias W Giessen; Michael Baym; S Jordan Kerns; Matthew J Niederhuber; Roderick T Bronson; Jonathan W Kotula; Georg K Gerber; Jeffrey C Way; Pamela A Silver
Journal:  Nat Biotechnol       Date:  2017-05-29       Impact factor: 54.908

4.  Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial.

Authors:  A Stewart Campbell; Brittany D Needham; Christopher R Meyer; Joanna Tan; Mary Conrad; Gregory M Preston; Federico Bolognani; Srinivas G Rao; Helen Heussler; Rebecca Griffith; Adam J Guastella; Amy C Janes; Blaise Frederick; David H Donabedian; Sarkis K Mazmanian
Journal:  Nat Med       Date:  2022-02-14       Impact factor: 53.440

5.  Unravelling the collateral damage of antibiotics on gut bacteria.

Authors:  Lisa Maier; Camille V Goemans; Jakob Wirbel; Michael Kuhn; Claudia Eberl; Mihaela Pruteanu; Patrick Müller; Sarela Garcia-Santamarina; Elisabetta Cacace; Boyao Zhang; Cordula Gekeler; Tisya Banerjee; Exene Erin Anderson; Alessio Milanese; Ulrike Löber; Sofia K Forslund; Kiran Raosaheb Patil; Michael Zimmermann; Bärbel Stecher; Georg Zeller; Peer Bork; Athanasios Typas
Journal:  Nature       Date:  2021-10-13       Impact factor: 69.504

Review 6.  Psoriasis and Gut Microbiome-Current State of Art.

Authors:  Karina Polak; Beata Bergler-Czop; Michał Szczepanek; Kamila Wojciechowska; Aleksandra Frątczak; Norbert Kiss
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Extensive impact of non-antibiotic drugs on human gut bacteria.

Authors:  Lisa Maier; Mihaela Pruteanu; Michael Kuhn; Georg Zeller; Anja Telzerow; Exene Erin Anderson; Ana Rita Brochado; Keith Conrad Fernandez; Hitomi Dose; Hirotada Mori; Kiran Raosaheb Patil; Peer Bork; Athanasios Typas
Journal:  Nature       Date:  2018-03-19       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.